Lipocine's stock rockets on premarket leading volume after upbeat liver fat study results [MarketWatch]
Lipocine Inc. (LPCN)
Last lipocine inc. earnings: 11/12 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.lipocine.com
Company Research
Source: MarketWatch
Lipocine's stock rockets on premarket leading volume after upbeat liver fat study results Shares of Lipocine Inc. LPCN, +46.54% rocketed 49% toward a one-year high in very active premarket trade Thursday, after the pharmaceutical company reported upbeat interim results of a study of its treatment for non-alcoholic steatohepatitis (NASH). Volume ballooned to 3.2 million shares, compared with the full-day average of about 88,500 shares, and enough to make the stock the most actively traded ahead of the open. The company said its LPCN 1144 NASH treatment showed an "absolute mean reduction" from baseline of 7.6% liver fat and deomonstrated a 38% relative mean liver fat reduction from baseline. The responder rate, in which at least a 4.1% absolute reduction in liver fat from baseline was experienced was 86%. The study showed that LPCN 1144 was well tolerated. "We are very encouraged by these results especially as the observed liver fat reductions are the largest of any well-tolerated or
Show less
Read more
Impact Snapshot
Event Time:
LPCN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LPCN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LPCN alerts
High impacting Lipocine Inc. news events
Weekly update
A roundup of the hottest topics
LPCN
News
- Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154 [Yahoo! Finance]Yahoo! Finance
- Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154PR Newswire
- Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
LPCN
Earnings
- 11/8/23 - Miss
LPCN
Sec Filings
- 3/25/24 - Form 8-K
- 3/12/24 - Form 4
- 3/12/24 - Form 4
- LPCN's page on the SEC website